Skip to Main Content
Pharmacy Technician's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Cardiology
  4. Hypertension
  5. Treatment
  6. ARBs

ARBs

  • Angina (16)
  • Antithrombotics (219)
  • Arrhythmias (115)
  • Blood Pressure (36)
  • Cardiovascular Disease and Depression (6)
  • Cholesterol (87)
  • Dyslipidemia (220)
  • Endocarditis (17)
  • Heart Disease (69)
  • Heart Failure (155)
  • Hypertension (226)
    • Monitoring (42)
    • Prevention (18)
    • Treatment (187)
      • ACEIs (113)
      • ARBs (110)
      • Beta-Blockers (70)
      • Calcium Channel Blockers (77)
      • Direct Renin Inhibitors (20)
      • Diuretics (75)
      • Other (43)
      • Spironolactone (21)
      • Treatment of Pediatric Hypertension (5)
      • Treatment of Resistant Hypertension (12)
  • Hypotension (15)
  • Ischemic Heart Disease/Acute Coronary Syndromes (272)
  • Myocardial Infarction (40)
  • Peripheral Vascular Disease (5)
  • Pulmonary Arterial Hypertension (1)
  • Raynaud's (2)
  • Resources (666)
  • Stroke (114)
91 - 105 of 110 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Guideline: Combination Therapy in Hypertension (2010) October 2010
Article: drug combos for high blood pressure October 2010
Commentary: Olmesartan (Benicar) and Cardiovascular Risk August 2010
Commentary: Angiotensin Receptor Blockers (ARBs) and Cancer Risk August 2010
Article: whether losartan or other angiotensin receptor blockers (ARBs) cause cancer or heart problems August 2010
Article: Losartan will be the first GENERIC angiotensin receptor blocker March 2010
Article: Valturna, a new combination of Diovan (valsartan) and Tekturna (aliskiren) for high blood pressure December 2009
Chart: Histamine H2 Blocker Oral Dose Comparison August 2009
Other: Sample Collaborative Practice Agreement August 2009
Chart: Sulfonylurea Dose Comparison August 2009
Chart: Collaborative Drug Therapy Management (CDTM) August 2009
Article: how to handle non-formulary drug requests August 2009
Chart: Proton Pump Inhibitor Dose Comparison August 2009
Guideline: 2008 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk August 2007
Guideline: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7 Express) (2007) August 2007
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved